• Home
  1. Home
  2. Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution
Scientific article
English

Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution

ContributorsLauper, Kimorcid; Mongin, Denisorcid; Alpizar Rodriguez, Deshire; Codreanu, Catalin; Iannone, Florenzo; Kristianslund, Eirik K; Kvien, Tore K; Pavelka, Karel; Pombo-Suarez, Manuel; Santos, Maria J; Gabay, Cem; Finckh, Axelorcid; Courvoisier, Delphineorcid
Published inRheumatology, vol. 58, no. 12, p. 2221-2229
Publication date2019
Abstract

To examine the association of the evolution in physician-reported and patient-reported outcomes with decision to stop biological DMARDs (bDMARDs) in RA. The contribution of baseline characteristics is well established, but little is known about how the disease evolution influences the decision to discontinue therapy.

Affiliation entities
Research groups
Citation (ISO format)
LAUPER, Kim et al. Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution. In: Rheumatology, 2019, vol. 58, n° 12, p. 2221–2229. doi: 10.1093/rheumatology/kez221
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1462-0324
378views
0downloads

Technical informations

Creation06/01/2020 08:00:00
First validation06/01/2020 08:00:00
Update13/10/2025 17:46:14
Status update03/02/2025 12:54:37
Last indexation21/08/2026 16:49:12
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack